KuppingerCole: RSA an Overall Leader in Identity Governance, the Cornerstone of Zero Trust
RSA recognized as an Overall Leader for the fourth consecutive year in the 2022 KuppingerCole…
RSA recognized as an Overall Leader for the fourth consecutive year in the 2022 KuppingerCole…
ZÜRICH, Switzerland, Dec. 08, 2022 (GLOBE NEWSWIRE) — CDR-Life Inc., a biotechnology company pioneering a…
8 December 2022 Clinigen notes results from the MIROCALS trial investigating low dose Proleukin® (aldesleukin)…
12 out of 14 patients went into remission for three months following a single 25mg…
Listing on the Main Market can increase visibility, which may allow the company to appear…
Robert Wessman Founder and Executive Chairman will ring the Nasdaq Iceland closing bell at 15:30…
LISBON, Portugal, Dec. 08, 2022 (GLOBE NEWSWIRE) — Stratio, the leading provider of predictive maintenance…
BlueMagic Group is a leading hair transplant clinic in Turkey, providing top-rated service for thousands…
KUALA LUMPUR, Dec 8, 2022 – (ACN Newswire) – Propel Global Berhad (Bursa: MAIN, PGB,…
KUCHING, MALAYSIA, Dec 8, 2022 – (ACN Newswire) – Civil engineering specialist Sarawak Consolidated Industries…
EL DORADO HILLS, Calif.–(BUSINESS WIRE)–Aetina, an edge AI solution provider that offers embedded computing hardware…
NEW YORK–(BUSINESS WIRE)–BrightHire, the leading interview intelligence platform for improving the quality of hiring, announced…
Pediatric mental health utilization to cost U.S. employers nearly three times as much in 2023,…
DUBLIN–(BUSINESS WIRE)–The “Disaster Recovery Business Continuity and Security Manual Templates Bundle” report has been added…
DUBLIN–(BUSINESS WIRE)–The “CIO Infrastructure Management Tool Kit – Standard Edition” report has been added to…
Onfido reveals emerging fraud trends from its annual Identity Fraud Report Foreword from Interpol highlights…
Mobile messaging campaigns generate 22.5x ROI in five days London, São Paulo, 08 December 2022…
FAIRFAX, VA., USA – 8 December 2022 – TEOCO, the leading provider of analytics, assurance…
Geneva, Switzerland, 8 December 2022 — iOnctura SA a clinical-stage biotech developing selective cancer therapies…
Agreements build on Sosei Heptares’ Target Identification and Validation strategy and translational medicine approach to…